FBT
NVO

Founders Bank & Trust’s Novo Nordisk NVO Stock Holding History

Founders Bank & Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$153K Buy
7,244
+438
+6% +$9.78K 0.08% 118
2014
Q3 		$162K Hold
6,806
– – 0.09% 107
2014
Q2 		$157K Buy
6,806
+2,528
+59% +$55.8K 0.09% 106
2014
Q1 		$98K Sell
4,278
-7,452
-64% -$159K 0.06% 126
2013
Q4 		$48K Buy
+11,730
New +$204K 0.03% 173

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Founders Bank & Trust's NVO Position: Q4 2014 in Review

Founders Bank & Trust increased its Novo Nordisk (NVO) stake by 6.4% in Q4 2014, buying an estimated $9.78K and bringing the position to 7,244 shares worth $153K. The position accounts for 0.08% of the portfolio, ranked #118.

Founders Bank & Trust first reported a position in NVO in Q4 2013 and has held it in 5 quarters since. The position peaked at $162K in Q3 2014. 500 funds tracked by Wall St. Rank hold NVO as of Q4 2014.

  • Founders Bank & Trust held 7,244 shares of Novo Nordisk worth $153K as of Q4 2014.
  • Founders Bank & Trust bought 438 Novo Nordisk shares in Q4 2014, an estimated $9.78K.
  • Novo Nordisk made up 0.08% of Founders Bank & Trust's portfolio in Q4 2014, its #118 holding.
  • Founders Bank & Trust first reported a position in Novo Nordisk in Q4 2013 and has held it in 5 quarters since.
  • Founders Bank & Trust's Novo Nordisk position peaked at $162K in Q3 2014.
  • 500 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2014.

Based on Founders Bank & Trust's 13F filing for Q4 2014, filed 9 Feb 2015.